<bill session="108" type="h" number="4747" updated="2013-07-14T19:02:41-04:00">
  <state datetime="2004-06-25">REFERRED</state>
  <status>
    <introduced datetime="2004-06-25"/>
  </status>
  <introduced datetime="2004-06-25"/>
  <titles>
    <title as="introduced" type="short">Dietary Supplement Regulatory Implementation Act of 2004</title>
    <title as="introduced" type="official">To ensure that the goals of the Dietary Supplement Health and Education Act of 1994 are met by authorizing appropriations to fully enforce and implement such Act and the amendments made by such Act, and for other purposes.</title>
  </titles>
  <sponsor id="400308"/>
  <cosponsors>
    <cosponsor id="400073" joined="2004-07-15"/>
    <cosponsor id="400178" joined="2004-10-05"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2004-06-25">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2004-07-07">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="108" type="h" number="4760"/>
  </relatedbills>
  <subjects>
    <term name="Agriculture and food"/>
    <term name="Administrative procedure"/>
    <term name="Appropriations"/>
    <term name="Authorization"/>
    <term name="Business records"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Consumer protection"/>
    <term name="Deceptive advertising"/>
    <term name="Defective products"/>
    <term name="Department of Health and Human Services"/>
    <term name="Dietary supplements"/>
    <term name="Drug interactions"/>
    <term name="Economics and public finance"/>
    <term name="Electronic government information"/>
    <term name="Federal aid to research"/>
    <term name="Federal employees"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Food industry"/>
    <term name="Food safety"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Health"/>
    <term name="Health education"/>
    <term name="Internet"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Legislation"/>
    <term name="Medical records"/>
    <term name="Medical research"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Public service advertising"/>
    <term name="Research and development"/>
    <term name="Research grants"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>6/25/2004--Introduced.
Dietary Supplement Regulatory Implementation Act of 2004 - Makes appropriations for FY 2005, and authorizes appropriations for FY 2006 through 2009: (1) to carry out the Dietary Supplement Health and Education Act of 1994 (DSHEA), the amendments made by DSHEA, and all applicable regulatory requirements for dietary supplements under the Federal Food, Drug, and Cosmetic Act; and (2) for expanded research and development of consumer information, including information on safety and beneficial effects, of dietary supplements by the Office of Dietary Supplements at the National Institutes of Health. Directs the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to: (1) fully and appropriately use such funds to regulate dietary supplements; (2) report annually on DSHEA implementation and enforcement; (3) carry out programs to educate health professionals and consumers on the safety and health benefits of the dietary supplements, including the potential for interactions of dietary supplements and drugs (using specified funds authorized by this Act); and (4) establish a system for the requirements for the reporting of serious adverse experiences associated with the use of a dietary supplement received by the manufacturer, packer, or distributor whose name appears on the label of the product. Expresses the sense of the Congress regarding dietary supplements containing ephedrine alkaloids.</summary>
</bill>
